Catalyst Wire Dossier Catalyst Wire Dossier

ALYACEN 1/35

NORETHINDRONE AND ETHINYL ESTRADIOL · Glenmark Pharmaceuticals Inc., USA
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALYACEN 1/35, covering 2012-01-19 to 2020-07-06. Get the full timeline:

Most recent: FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

See pricing